Affordable Medicines
May 18, 2018
Navigating the Generic Regulatory Landscape
Regulatory issues are increasingly challenging with the emergence of biosimilar medications and the proliferation of various tactics designed to extend market exclusivity.October 13, 2017
Biosimilar Milestone
June 16, 2017
Generic Drugs in the Pipeline: 2017 Update
June 16, 2017
An Overview of Generic Triptans for Migraine
June 16, 2017
AAM Update on the Status of Generic Drugs
June 16, 2017
Getting a Handle on Generic-Drug Prices
February 16, 2017
Biosimilars in Oncology
December 21, 2016
Graphic Changes Aid Identification of Active OTC Ingredients
December 16, 2016
Legal Aspects of Biosimilars
November 17, 2016
The Impact of Generic Medications on Breast Cancer Prevention
November 17, 2016
Cancer Biosimilars: Regulation Challenges and Clinical Impact
October 14, 2016
FDA Approves Two Biosimilars
Copyright © 2000 - 2018 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.